-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
With the intensification of aging and the continuous upgrading of consumption, the big health industry is showing a strong momentum of development
.
According to incomplete statistics, the market size of the big health industry has reached 7 trillion yuan in 2020.
Following this trend, the industry predicts that the market may exceed 8 trillion yuan by 2022
.
In the context of the vigorous development of the big health industry, the concept of big health is continuing to be hot, and more and more pharmaceutical companies have begun to play the "health" brand, trying to break the single product structure across the border
.
It is reported that on April 19, Huahai Pharmaceutical newly established Zhejiang Freeze-Drying Technology Co.
, Ltd.
with a registered capital of 10 million, which is wholly-owned by Huahai Health Technology (Zhejiang) Co.
, Ltd.
, a wholly-owned subsidiary of Huahai Pharmaceutical.
A scientific and technological innovation company in the health field, its business scope includes technology development and promotion; food sales; health food (pre-packaged) sales,
etc.
According to public information, Huahai Health was changed from Zhejiang Huahai Yisheng Health Food Co.
, Ltd.
on November 29, 2021, and its business scope has also changed.
Now its business scope includes health food (prepackaged) sales; food Internet sales (Only prepackaged food is sold),
etc.
According to reports, the business expansion of Huahai Great Health is based on the rapid upgrade of health requirements in the current food category consumer market
.
Therefore, Huahai Pharmaceutical has launched the first brand of the big health sector - "freeze-drying" at the node of the current market consumption upgrading and transformation
.
It is worth noting that this also marks that Huahai Pharmaceutical has entered a new stage in its strategic layout of big health
.
In fact, in the pharmaceutical industry, the "cross-border" trend of pharmaceutical companies has never stopped
.
It is reported that pharmaceutical companies such as Tong Ren Tang, Ma Yinglong, and China Resources Sanjiu have already deployed in the field of beauty
.
In recent years, many pharmaceutical companies in the tea, daily necessities and other industries have entered the market
.
For example, in 2021, the "Zhenyinzi" tea brand under the traditional pharmaceutical company North China Pharmaceutical announced that it will soon start attracting investment
.
The tea brand has promoted the "national tide" health feature in its publicity
.
It is understood that the "Zhen Yinzi" brand belongs to Hebei Huawei Health Industry Co.
, Ltd.
, and North China Pharmaceutical holds 51% of the company's equity
.
The analysis believes that North China Pharmaceutical's new tea business is mainly to seek new growth points
.
On July 30, 2021, Renhe Pharmaceutical announced the acquisition of 7 cosmetics companies, with a total transaction value of 720 million yuan
.
Also in July, Dong'e Ejiao also announced the launch of its first independent beauty brand "Peach Blossom Run"
.
In the early years, Pien Tze Huang Pharmaceutical Co.
, Ltd.
and Zhangzhou Chemical Factory jointly invested and formed Fujian Pien Tze Huang Cosmetics Co.
, Ltd.
; Tongrentang established an Asian skin care center and launched a series of herbal cosmetics; Ma Yinglong, a pharmaceutical company focusing on hemorrhoids, launched "Eight Treasures" "Gufang" eye cream products; China Resources Sanjiu, which produces 999 Piyanping and 999 Ganmaoling, launched the "Hedinghong" lipstick set.
.
.
On the whole, in the face of the fiercely competitive market, pharmaceutical companies have become more frequent and diverse Hundreds
of.
In addition to daily chemicals, beauty cosmetics, and tea, pharmaceutical companies have even made arrangements in business areas such as lottery
.
However, it should be noted that although the cross-border operation of domestic pharmaceutical companies has been very rich, covering many fields from daily chemicals to health care to maternal and child maternity, so far, the cross-border operation in the pharmaceutical industry has been successful.
still very few
.
The industry believes that this reminds pharmaceutical companies that want to play big health through cross-border business, and it is not easy to open up a new situation with cross-border business alone
.
Relevant enterprises also need to prioritize their operations before crossing the border.
On the basis of ensuring the healthy development of the original business, they must gain an in-depth insight into the real needs of consumers, and then try to cross the border according to their own resources and characteristics
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
According to incomplete statistics, the market size of the big health industry has reached 7 trillion yuan in 2020.
Following this trend, the industry predicts that the market may exceed 8 trillion yuan by 2022
.
In the context of the vigorous development of the big health industry, the concept of big health is continuing to be hot, and more and more pharmaceutical companies have begun to play the "health" brand, trying to break the single product structure across the border
.
It is reported that on April 19, Huahai Pharmaceutical newly established Zhejiang Freeze-Drying Technology Co.
, Ltd.
with a registered capital of 10 million, which is wholly-owned by Huahai Health Technology (Zhejiang) Co.
, Ltd.
, a wholly-owned subsidiary of Huahai Pharmaceutical.
A scientific and technological innovation company in the health field, its business scope includes technology development and promotion; food sales; health food (pre-packaged) sales,
etc.
According to public information, Huahai Health was changed from Zhejiang Huahai Yisheng Health Food Co.
, Ltd.
on November 29, 2021, and its business scope has also changed.
Now its business scope includes health food (prepackaged) sales; food Internet sales (Only prepackaged food is sold),
etc.
According to reports, the business expansion of Huahai Great Health is based on the rapid upgrade of health requirements in the current food category consumer market
.
Therefore, Huahai Pharmaceutical has launched the first brand of the big health sector - "freeze-drying" at the node of the current market consumption upgrading and transformation
.
It is worth noting that this also marks that Huahai Pharmaceutical has entered a new stage in its strategic layout of big health
.
In fact, in the pharmaceutical industry, the "cross-border" trend of pharmaceutical companies has never stopped
.
It is reported that pharmaceutical companies such as Tong Ren Tang, Ma Yinglong, and China Resources Sanjiu have already deployed in the field of beauty
.
In recent years, many pharmaceutical companies in the tea, daily necessities and other industries have entered the market
.
For example, in 2021, the "Zhenyinzi" tea brand under the traditional pharmaceutical company North China Pharmaceutical announced that it will soon start attracting investment
.
The tea brand has promoted the "national tide" health feature in its publicity
.
It is understood that the "Zhen Yinzi" brand belongs to Hebei Huawei Health Industry Co.
, Ltd.
, and North China Pharmaceutical holds 51% of the company's equity
.
The analysis believes that North China Pharmaceutical's new tea business is mainly to seek new growth points
.
On July 30, 2021, Renhe Pharmaceutical announced the acquisition of 7 cosmetics companies, with a total transaction value of 720 million yuan
.
Also in July, Dong'e Ejiao also announced the launch of its first independent beauty brand "Peach Blossom Run"
.
In the early years, Pien Tze Huang Pharmaceutical Co.
, Ltd.
and Zhangzhou Chemical Factory jointly invested and formed Fujian Pien Tze Huang Cosmetics Co.
, Ltd.
; Tongrentang established an Asian skin care center and launched a series of herbal cosmetics; Ma Yinglong, a pharmaceutical company focusing on hemorrhoids, launched "Eight Treasures" "Gufang" eye cream products; China Resources Sanjiu, which produces 999 Piyanping and 999 Ganmaoling, launched the "Hedinghong" lipstick set.
.
.
On the whole, in the face of the fiercely competitive market, pharmaceutical companies have become more frequent and diverse Hundreds
of.
In addition to daily chemicals, beauty cosmetics, and tea, pharmaceutical companies have even made arrangements in business areas such as lottery
.
However, it should be noted that although the cross-border operation of domestic pharmaceutical companies has been very rich, covering many fields from daily chemicals to health care to maternal and child maternity, so far, the cross-border operation in the pharmaceutical industry has been successful.
still very few
.
The industry believes that this reminds pharmaceutical companies that want to play big health through cross-border business, and it is not easy to open up a new situation with cross-border business alone
.
Relevant enterprises also need to prioritize their operations before crossing the border.
On the basis of ensuring the healthy development of the original business, they must gain an in-depth insight into the real needs of consumers, and then try to cross the border according to their own resources and characteristics
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
